Literature DB >> 9262572

Treatment strategy for patients with surgically discovered N2 stage IIIA non-small cell lung cancer.

R Nakanishi1, T Osaki, K Nakanishi, I Yoshino, T Yoshimatsu, H Watanabe, H Nakata, K Yasumoto.   

Abstract

BACKGROUND: The treatment strategy for patients with non-small cell lung cancer and clinically negative, but surgically detected mediastinal lymph node metastasis (surgically discovered N2 disease) is controversial.
METHODS: From August 1979 through December 1994, 53 patients with non-small cell lung cancer were found to have surgically discovered N2 disease. We retrospectively studied the clinical characteristics and the factors that influenced the prognosis in these patients.
RESULTS: The 3-year and 5-year survival rates and the median survival for the 53 patients with surgically discovered N2 disease were 44%, 21%, and 26 months. Two thirds of the patients had adenocarcinoma. Only complete resection affected long-term survival; adjuvant therapy had no effect on survival. In regard to lymph node status, a single metastatic focus in the aortic area was associated with long-term survival.
CONCLUSIONS: Patients with adenocarcinoma may require histologic determination of N2 disease. Complete resection, including extensive and complete mediastinal lymph node dissection, is warranted in patients with surgically discovered N2 disease. In particular, when the aortic lymph node (including stations 5 and 6) alone is involved, the patients should undergo as complete a resection as possible.

Entities:  

Mesh:

Year:  1997        PMID: 9262572     DOI: 10.1016/S0003-4975(97)00535-3

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  7 in total

1.  Long-term outcomes after lobectomy for non-small cell lung cancer when unsuspected pN2 disease is found: A National Cancer Data Base analysis.

Authors:  Chi-Fu Jeffrey Yang; Arvind Kumar; Brian C Gulack; Michael S Mulvihill; Matthew G Hartwig; Xiaofei Wang; Thomas A D'Amico; Mark F Berry
Journal:  J Thorac Cardiovasc Surg       Date:  2015-12-21       Impact factor: 5.209

2.  Prognostic significance of proliferative activity in pN2 non-small-cell lung carcinomas and their mediastinal lymph node metastases.

Authors:  T Fukuse; T Hirata; H Naiki; S Hitomi; H Wada
Journal:  Ann Surg       Date:  2000-07       Impact factor: 12.969

3.  Video-assisted thoracic surgery involving major pulmonary resection for central tumors.

Authors:  Ryoichi Nakanishi; Yoshihisa Fujino; Soichi Oka; Seiichi Odate
Journal:  Surg Endosc       Date:  2009-06-11       Impact factor: 4.584

4.  Long term and disease-free survival following surgical resection of occult N2 lung cancer.

Authors:  Bilal H Kirmani; Sara Volpi; Giuseppe Aresu; Adam Peryt; Thida Win; Aman S Coonar
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

5.  Mediastinal lymph node metastasis model by orthotopic intrapulmonary implantation of Lewis lung carcinoma cells in mice.

Authors:  Y Doki; K Murakami; T Yamaura; S Sugiyama; T Misaki; I Saiki
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

Review 6.  Resectable IIIA-N2 Non-Small-Cell Lung Cancer (NSCLC): In Search for the Proper Treatment.

Authors:  Debora Brascia; Giulia De Iaco; Marcella Schiavone; Teodora Panza; Francesca Signore; Alessandro Geronimo; Doroty Sampietro; Michele Montrone; Domenico Galetta; Giuseppe Marulli
Journal:  Cancers (Basel)       Date:  2020-07-25       Impact factor: 6.639

7.  Location of stage I-III non-small cell lung cancer and survival rate: Systematic review and meta-analysis.

Authors:  Hyun Woo Lee; Chang-Hoon Lee; Young Sik Park
Journal:  Thorac Cancer       Date:  2018-09-27       Impact factor: 3.500

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.